Oppenheimer & CO Inc Astrazeneca PLC Transaction History

Oppenheimer & CO Inc

  • $6.52 Billion
  • Q4 2024

A detailed history of Oppenheimer & CO Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Oppenheimer & CO Inc holds 23,925 shares of AZN stock, worth $1.72 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,925
Previous 22,564 6.03%
Holding current value
$1.72 Million
Previous $1.76 Million 10.86%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
BUY
$63.2 - $79.58 $86,015 - $108,308
1,361 Added 6.03%
23,925 $1.57 Million
Q3 2024

Nov 05, 2024
BUY
$76.67 - $87.62 $459,943 - $525,632
5,999 Added 36.21%
22,564 $1.76 Million
Q2 2024

Aug 07, 2024
SELL
$66.81 - $80.83 $113,777 - $137,653
-1,703 Reduced 9.32%
16,565 $1.29 Million
Q1 2024

May 06, 2024
BUY
$61.03 - $69.57 $103,384 - $117,851
1,694 Added 10.22%
18,268 $1.24 Million
Q4 2023

Feb 13, 2024
BUY
$61.89 - $69.28 $133,063 - $148,952
2,150 Added 14.91%
16,574 $1.12 Million
Q3 2023

Nov 07, 2023
BUY
$64.85 - $71.7 $318,997 - $352,692
4,919 Added 51.75%
14,424 $976,000
Q2 2023

Aug 02, 2023
SELL
$69.91 - $75.81 $64,037 - $69,441
-916 Reduced 8.79%
9,505 $680,000
Q1 2023

May 10, 2023
SELL
$63.15 - $71.6 $48,309 - $54,773
-765 Reduced 6.84%
10,421 $723,000
Q4 2022

Feb 07, 2023
BUY
$54.21 - $70.44 $8,998 - $11,693
166 Added 1.51%
11,186 $758,000
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $202,748 - $519,108
-3,824 Reduced 25.76%
11,020 $604,000
Q2 2022

Aug 08, 2022
BUY
$59.26 - $71.14 $132,860 - $159,495
2,242 Added 17.79%
14,844 $980,000
Q1 2022

May 12, 2022
BUY
$55.72 - $67.12 $11,311 - $13,625
203 Added 1.64%
12,602 $836,000
Q4 2021

Feb 02, 2022
BUY
$54.02 - $63.83 $15,935 - $18,829
295 Added 2.44%
12,399 $722,000
Q3 2021

Nov 12, 2021
SELL
$55.56 - $60.79 $135,677 - $148,449
-2,442 Reduced 16.79%
12,104 $727,000
Q2 2021

Aug 03, 2021
SELL
$48.42 - $60.18 $495,772 - $616,183
-10,239 Reduced 41.31%
14,546 $872,000
Q1 2021

May 10, 2021
BUY
$47.16 - $54.44 $1,886 - $2,177
40 Added 0.16%
24,785 $1.23 Million
Q4 2020

Feb 11, 2021
SELL
$48.52 - $58.02 $164,676 - $196,919
-3,394 Reduced 12.06%
24,745 $1.24 Million
Q3 2020

Nov 13, 2020
BUY
$53.07 - $61.1 $721,858 - $831,082
13,602 Added 93.57%
28,139 $1.54 Million
Q2 2020

Aug 11, 2020
BUY
$43.1 - $55.31 $270,883 - $347,623
6,285 Added 76.16%
14,537 $768,000
Q1 2020

May 08, 2020
SELL
$37.79 - $51.33 $612,840 - $832,418
-16,217 Reduced 66.28%
8,252 $368,000
Q4 2019

Feb 07, 2020
SELL
$42.46 - $50.46 $91,119 - $108,287
-2,146 Reduced 8.06%
24,469 $1.22 Million
Q3 2019

Oct 31, 2019
SELL
$40.12 - $45.47 $13,560 - $15,368
-338 Reduced 1.25%
26,615 $1.19 Million
Q2 2019

Aug 09, 2019
SELL
$37.28 - $41.68 $39,293 - $43,930
-1,054 Reduced 3.76%
26,953 $1.11 Million
Q1 2019

Apr 24, 2019
BUY
$35.49 - $43.02 $15,828 - $19,186
446 Added 1.62%
28,007 $1.13 Million
Q4 2018

Jan 29, 2019
SELL
$36.86 - $41.49 $344,456 - $387,724
-9,345 Reduced 25.32%
27,561 $1.05 Million
Q3 2018

Oct 26, 2018
SELL
$34.76 - $39.72 $25,201 - $28,797
-725 Reduced 1.93%
36,906 $1.46 Million
Q2 2018

Aug 10, 2018
BUY
$34.55 - $37.05 $44,673 - $47,905
1,293 Added 3.56%
37,631 $1.32 Million
Q1 2018

May 01, 2018
BUY
$32.97 - $36.63 $226,042 - $251,135
6,856 Added 23.25%
36,338 $1.27 Million
Q4 2017

Feb 07, 2018
BUY
$32.09 - $34.78 $425,770 - $461,461
13,268 Added 81.83%
29,482 $1.02 Million
Q3 2017

Nov 09, 2017
BUY
$28.96 - $34.0 $469,557 - $551,276
16,214
16,214 $550,000

Others Institutions Holding AZN

# of Institutions
1,350
Shares Held
477M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $223B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email